Cargando…
Antibody-Mediated Inhibition of TNFR1 Attenuates Disease in a Mouse Model of Multiple Sclerosis
Tumour necrosis factor (TNF) is a proinflammatory cytokine that is known to regulate inflammation in a number of autoimmune diseases, including multiple sclerosis (MS). Although targeting of TNF in models of MS has been successful, the pathological role of TNF in MS remains unclear due to clinical t...
Autores principales: | Williams, Sarah K., Maier, Olaf, Fischer, Roman, Fairless, Richard, Hochmeister, Sonja, Stojic, Aleksandar, Pick, Lara, Haar, Doreen, Musiol, Sylvia, Storch, Maria K., Pfizenmaier, Klaus, Diem, Ricarda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3938650/ https://www.ncbi.nlm.nih.gov/pubmed/24587232 http://dx.doi.org/10.1371/journal.pone.0090117 |
Ejemplares similares
-
Co-modulation of TNFR1 and TNFR2 in an animal model of multiple sclerosis
por: Fiedler, Timon, et al.
Publicado: (2023) -
Anti-TNFR1 targeting in humanized mice ameliorates disease in a model of multiple sclerosis
por: Williams, Sarah K., et al.
Publicado: (2018) -
The TNFR1 Antagonist Atrosimab Is Therapeutic in Mouse Models of Acute and Chronic Inflammation
por: Richter, Fabian, et al.
Publicado: (2021) -
Preclinical stress originates in the rat optic nerve head during development of autoimmune optic neuritis
por: Stojic, Aleksandar, et al.
Publicado: (2018) -
Anti-inflammatory treatment in MPN: targeting TNFR1 and TNFR2 in JAK2-V617F–induced disease
por: Müller, Peter, et al.
Publicado: (2021)